C
CGN
vs
REGN
REGN
Over the past 12 months, CGN has underperformed REGN, delivering a return of 0% compared to the REGN's +10% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
REGN
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
C
|
Cognetivity Neurosciences Ltd
CNSX:CGN
|
0.01
CAD
|
|||||
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
752.43
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
CGN, REGN
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
C
|
Cognetivity Neurosciences Ltd
Revenue
|
|||||||||||
|
Regeneron Pharmaceuticals Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
CGN, REGN
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
C
|
Cognetivity Neurosciences Ltd
CNSX:CGN
|
|||||||||
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Cognetivity Neurosciences Ltd | ||||
|
Regeneron Pharmaceuticals Inc | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Cognetivity Neurosciences Ltd | ||||
|
Regeneron Pharmaceuticals Inc | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Cognetivity Neurosciences Ltd | ||||
|
Regeneron Pharmaceuticals Inc | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Cognetivity Neurosciences Ltd | ||||
|
Regeneron Pharmaceuticals Inc | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Cognetivity Neurosciences Ltd | ||||
|
Regeneron Pharmaceuticals Inc | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Cognetivity Neurosciences Ltd | ||||
|
Regeneron Pharmaceuticals Inc | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Cognetivity Neurosciences Ltd | ||||
|
Regeneron Pharmaceuticals Inc | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Cognetivity Neurosciences Ltd | ||||
|
Regeneron Pharmaceuticals Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
CGN, REGN
Performance Gap
CGN, REGN
Performance By Year
CGN, REGN
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.